Who is sponsoring NCT03411018?

NCT03411018 is sponsored by Manuel Sanchez Luna.

What drugs are being tested in NCT03411018?

Interventions in NCT03411018: Mechanical ventilation exposure.

What condition does NCT03411018 study?

NCT03411018 studies Bronchopulmonary Dysplasia.

Is NCT03411018 still recruiting?

NCT03411018 is currently completed. Last updated 27 August 2021.

Last reviewed 2021-08-27 · How we verify

NCT03411018

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia

Completed Last updated 27 August 2021

What this trial tests

trial testing Mechanical ventilation exposure in Bronchopulmonary Dysplasia in 600 participants. Completed in 31 December 2017.

Timeline

1 January 2012

Primary endpoint
31 December 2017

31 December 2017

Quick facts

Lead sponsor	Manuel Sanchez Luna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	600
Start date	1 January 2012
Primary completion	31 December 2017
Estimated completion	31 December 2017
Sites	1 location across Spain

Drugs / interventions tested

Mechanical ventilation exposure

Conditions studied

Bronchopulmonary Dysplasia — all drugs for Bronchopulmonary Dysplasia →

Sponsor

Manuel Sanchez Luna

Who can join

Under 36 Weeks, any sex, with Bronchopulmonary Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study evaluates the impact of respiratory management modifications implemented in our institution on the intubation rates and the death or Bronchopulmonary Dysplasia (BPD) outcome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of a new respiratory care bundle on bronchopulmonary dysplasia in preterm neonates.
Ramos-Navarro C, González-Pacheco N, Rodríguez-Sánchez de la Blanca A, Sánchez-Luna M. · · 2020 · cited 12× · PMID 32488737 · DOI 10.1007/s00431-020-03694-5

Verify or expand the search:

Other recruiting trials for Bronchopulmonary Dysplasia

Currently open trials in the same condition.

NCT06589245 — Inhaled Ciclesonide Study in Preterm Infants · Phase 1 · recruiting
NCT06512935 — Ventilator Pressure and Optimization of Compliance and Hemodynamics · NA · recruiting
NCT06534359 — Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia · NA · recruiting
NCT06808997 — Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preter · recruiting
NCT06897839 — Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03411018 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Manuel Sanchez Luna
Last refreshed: 27 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03411018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing